Back to All Events

Fireside chat with Laura Deming from AGE1, presented by BCLA and AGE1

  • One California Plaza 300 S. Grand Ave. #4100 Los Angeles, CA 90071 (map)

Register Here

—-

Biotech Connection LA brings you an exciting fireside chat and networking mixer with AGE1 at Nixon Peabody in downtown LA.

With  a primary focus on research into longevity and ageing, AGE1 founder Laura Deming will be speaking about  the cutting-edge reseach within the field, as well as the current opportunities availlable for researchers.

Don’t miss out the on opportunity to learn more about AGE1 and to network with fellow academics, entrepreneurs, and industry professionals over appetizers and drinks.

Join us on Nov 7th!

Stay tuned for more updates.

Event Schedule:

6.00 - 6.30 pm Registration 

6.30 - 7.00 pm Mix & Mingle

7.00 - 7.40 pm Fireside chat

7.40 - 8.30 pm Networking

Fireside Chat Speaker:

Laura Deming, Partner at The Longevity Fund

Since she was a kid, Laura has been fascinated by the idea that longevity is a mechanism we can manipulate. When she was 12, Laura moved to the US to take graduate coursework at UCSF before studying at MIT. She has worked in such groups as The Kenyon, Guarente, Weiss and Firestein labs on a number of topics, including aging and synthetic biology. In 2011, Laura started Longevity Fund, the first VC firm dedicated to funding high-potential longevity companies. So far, she’s raised $26M and have backed such companies as Unity Biotechnology, Decibel Therapeutics, Metacrine, Navitor, and System1. Building upon this success, Laura created the AGE1 Biotech accelerator to support early stage founder driven longevity companies, which look to develop therapeutics that will extend the human healthspan. Come join us for a conversation about her journey, and how to get involved with the AGE1 community. 

Sean Kim, Intellectual Property Transactional Attorney at Nixon Peabody LLP

Sean Kim is an associate in the Intellectual Property Counseling & Transactions group. His practice includes intellectual property counseling and commercial transactions, with a focus on technology and health care clients. He also serves as outside general counsel to more than 20 emerging growth companies. Prior to entering private practice, Sean was a patent agent at a multi-national technology corporation where he focused on IP procurement and commercialization.

Earlier Event: November 7
Women in Tech Breakfast